Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) (Q82294729)
scientific article published on 14 October 2008
Language:
(P31) (Q13442814)
(P50) (Q43055483)
(P304) 5326-5334
(P433) 33
(P478) 26
(P577) Tuesday, October 14, 2008
(P921) (Q188874)
(Q413299)
(Q108566365)
(Q25493920)
(P1433) (Q400292)
(P1476) "Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)" (language: en)
(P2093) Axel Grothey
Mary M Sugrue
David M Purdie
Wei Dong
Eric Hedrick
Mark Kozloff
other details
description scientific article published on 14 October 2008

External Links